WANBURY
|
The Current P/E Ratio of WANBURY is 15.70.
Share Price | ₹210.2 | Mar 13,2025 |
Market Cap | ₹689.5 Cr | |
Earnings-TTM | ₹43.9 Cr | TTM-Consolidated Results |
Price/Earnings | 15.70x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of WANBURY
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹689.5 Cr] as on Mar 13,2025
(/) Earnings [ ₹43.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 15.70x ]
Thus, for WANBURY , the investors are currently willing to pay 15.70 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WANBURY !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of WANBURY over the last five years.
Historical PE (Price/Earnings) ratio chart of WANBURY
PE Ratio Performance Analysis for WANBURY
- WANBURY 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.53x.
- WANBURY 's operated at median p/e ratio of 0.71x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/e ratio peaked in Mar2024 at 8.54x.
- WANBURY 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does WANBURY 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
WANBURY | 43.91 | 15.70 | 689.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.17 | 404,012.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 72.18 | 149,188.0 |
CIPLA LTD | 5,000.43 | 23.61 | 118,041.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 55.59 | 103,512.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.03 | 92,445.1 |
MANKIND PHARMA LTD | 2,050.73 | 44.28 | 90,812.7 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.34 | 88,805.2 |
LUPIN LTD | 2,892.10 | 31.08 | 89,895.2 |
AUROBINDO PHARMA LTD | 3,500.25 | 18.16 | 63,577.4 |
ABBOTT INDIA LTD | 1,334.46 | 47.15 | 62,917.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WANBURY 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 15.70x |
Max industry PE | 72.18x |
Median industry PE | 31.08x |
Average industry PE | 34.48x |
You may also like the below Video Courses